← Leaderboards
Shan P Yu
Veterans Health Administration
$5,900,254
Attributed
$10,877,770
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2007–24$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,877,770 · 8
VA$0 · 4
By mechanism
R01$4,738,118 · 3
R44$2,896,549 · 1
R42$1,500,000 · 1
R41$883,728 · 1
R21$859,375 · 2
I01$0 · 2
Top collaborators
- Ling Wei10 shared
- Thomas A. Dix7 shared
- Robert E Gross5 shared
- Cathrin M Buetefisch2 shared
Most similar at Veterans Health Administration
Same institution · by research overlap
- Anant Madabhushi$18,556,814
- Alicia M. Koontz$0
Others in their field
Top investigators on “Investigation”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$681,473,477
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$448,008,305
- Judith S. Currier · University Of California Los Angeles$395,422,692
Research focus
InvestigationBrainNeuronsStrokeDisabilityIschemic StrokeCellsBaseCessation Of LifeRecovery Of FunctionCell DeathIn VivoInjuryInfarctionMouse ModelAnimalsIschemiaClinical TrialsPost StrokeStroke TherapyCell TypeIn VitroPre-ClinicalEffective Therapy
Grant awards (38)
Direct Reprogramming of the brain after ischemic stroke in the aged mouse$410,698
R01 · FY2024 · NS
Innovative memantine therapy for neuroprotective effects against ischemic stroke and Alzheimer's disease$0
I21 · FY2024 · VA · contact PI
Direct Reprogramming of the brain after ischemic stroke in the aged mouse$420,503
R01 · FY2023 · NS
Innovative memantine therapy for neuroprotective effects against ischemic stroke and Alzheimer's disease$0
I21 · FY2023 · VA · contact PI
Direct Reprogramming of the brain after ischemic stroke in the aged mouse$417,688
R01 · FY2022 · NS
The role of NMDA receptor subunit GluN3A in age and Alzheimer's disease-related dementia$195,625
R21 · FY2022 · AG · contact PI
Novel Regenerative Treatment of TBI and Post TBI Depression$0
I01 · FY2022 · VA · contact PI
Novel Regenerative Treatment of TBI and Post TBI Depression$0
I01 · FY2022 · VA · contact PI
Direct Reprogramming of the brain after ischemic stroke in the aged mouse$360,933
R01 · FY2021 · NS
The role of NMDA receptor subunit GluN3A in age and Alzheimer's disease-related dementia$234,750
R21 · FY2021 · AG · contact PI
Novel Regenerative Treatment of TBI and Post TBI Depression$0
I01 · FY2021 · VA · contact PI
Direct Reprogramming of the brain after ischemic stroke in the aged mouse$360,933
R01 · FY2020 · NS
Novel Regenerative Treatment of TBI and Post TBI Depression$0
I01 · FY2020 · VA · contact PI
Stroke Treatment by Chemically-induced Hypothermia$965,517
R44 · FY2019 · NS
Novel Regenerative Treatment of TBI and Post TBI Depression$0
I01 · FY2019 · VA · contact PI
Stroke Treatment by Chemically-induced Hypothermia$965,515
R44 · FY2018 · NS
Application of optogenetics in iPS cell transplantation therapy for ischemic stro$341,250
R01 · FY2018 · NS
Novel Regenerative Treatment of TBI and Post TBI Depression$0
I01 · FY2018 · VA · contact PI
Stroke Treatment by Chemically-induced Hypothermia$965,517
R44 · FY2017 · NS
Application of optogenetics in iPS cell transplantation therapy for ischemic stro$341,250
R01 · FY2017 · NS
Multielectrode Array System for Basic and Translational Research$0
IS1 · FY2017 · VA · contact PI
Stroke Treatment by Chemically-induced Hypothermia$706,207
R42 · FY2016 · NS
Application of optogenetics in iPS cell transplantation therapy for ischemic stro$341,250
R01 · FY2016 · NS
Non- invasive cortical stimulation as neuroprotective and regenerative treatment in stroke$195,000
R21 · FY2016 · NS
Protection of the Brain by Chemical Hypothermia$0
I01 · FY2016 · VA · contact PI
Stroke Treatment by Chemically-induced Hypothermia$793,793
R42 · FY2015 · NS
Application of optogenetics in iPS cell transplantation therapy for ischemic stro$341,250
R01 · FY2015 · NS
Non- invasive cortical stimulation as neuroprotective and regenerative treatment in stroke$234,000
R21 · FY2015 · NS
Protection of the Brain by Chemical Hypothermia$0
I01 · FY2015 · VA · contact PI
Protection of the Brain by Chemical Hypothermia$0
I01 · FY2015 · VA · contact PI
Protection of the Brain by Chemical Hypothermia$0
I01 · FY2015 · VA · contact PI
Application of optogenetics in iPS cell transplantation therapy for ischemic stro$341,250
R01 · FY2014 · NS
Stroke Treatment by Chemically-Induced Hypothermia$441,864
R41 · FY2012 · NS
Stroke Treatment by Chemically-Induced Hypothermia$441,864
R41 · FY2011 · NS
Neuroprotection NR3A in Cultured Neurons and Ischemic Neonates$265,825
R01 · FY2011 · NS · contact PI
Neuroprotection NR3A in Cultured Neurons and Ischemic Neonates$268,538
R01 · FY2010 · NS · contact PI
Neuroprotection NR3A in Cultured Neurons and Ischemic Neonates$271,250
R01 · FY2009 · NS · contact PI
Neuroprotection NR3A in Cultured Neurons and Ischemic Neonates$255,500
R01 · FY2007 · NS · contact PI